Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Short-term Borrowings
- The proportion of short-term borrowings relative to total liabilities and shareholders’ investment showed a slight decline from 0.31% in March 2020 to 0.27% by December 2021. Data for subsequent periods is unavailable, indicating either a reduction to an immaterial level or omission in reporting.
- Trade Accounts Payable
- This liability component increased steadily from 4.76% in March 2020 to a peak of 6.43% in March 2022, followed by fluctuations remaining mostly between 5.15% and 6.19% from mid-2022 into early 2025, reflecting a moderate variability but a generally higher weighting compared to the start of the period.
- Salaries, Wages and Commissions
- The share of this expense item increased from 1.42% in March 2020 to peaks around 2.18% in late 2021 and again in late 2024, with intermittent declines. The pattern suggests periodic increases that may relate to seasonal factors or operational fluctuations.
- Other Accrued Liabilities
- Values exhibited modest volatility, initially declining from 6.60% in March 2020 to around 6.12%-6.60% during 2020, then rising to a high near 7.85% in late 2022. Thereafter, a slight downward trend ensued, ending near 6.88% in early 2025. This indicates fluctuations in accrued obligations over time.
- Dividends Payable
- Dividends payable increased steadily from 0.95% in early 2020 to around 1.32% by mid-2024, followed by a slight decrease to approximately 1.27% by March 2025, signaling an upward trend in shareholder distributions within the period.
- Income Taxes Payable
- This liability demonstrated variability, starting at 0.25% in March 2020 and rising generally through the timeline to a peak near 0.96% in late 2024, before dropping to 0.60% in early 2025, indicating fluctuations in tax liabilities that may correlate with earnings and tax planning.
- Current Portion of Long-term Debt
- The proportion experienced significant fluctuations, starting at 1.89% in early 2020, dropping close to zero mid-2020 and late-2021, then rising sharply to over 3% by late 2022 and early 2023. Subsequent quarters saw oscillations with values between 0.62% and 2.90%, reflecting active debt refinancing or repayments.
- Current Liabilities
- Overall, current liabilities increased from 16.19% in March 2020 to a peak of 20.81% by late 2022, before declining toward 15.97% by March 2025. The pattern shows an accumulation of short-term obligations around 2022 followed by a reduction.
- Long-term Debt Excluding Current Portion
- A clear downward trend was observed, from 25.16% in early 2020 to approximately 15.64% by early 2025, implying a reduction in long-term indebtedness over the period under review.
- Post-employment Obligations, Deferred Income Taxes, and Other Long-term Liabilities
- This category steadily declined from 13.09% in March 2020 to 8.16% by March 2025, suggesting improvements in pension or deferred tax liabilities or changes in accounting estimates or obligations.
- Long-term Liabilities
- Long-term liabilities decreased from 38.25% in early 2020 to 23.79% by early 2025, consistent with the reductions observed in debt and other long-term obligations, reinforcing a deleveraging trend in longer-term liabilities.
- Total Liabilities
- Total liabilities fell substantially from 54.43% of total capital structure in March 2020 to 39.76% by March 2025, illustrating a significant shift toward lower leverage.
- Common Shares, Without Par Value, Issued at Stated Capital Amount
- The equity share represented by common shares was relatively steady, fluctuating around 33% to 35% through most of the measurement period before declining to approximately 30.85% by March 2025.
- Common Shares Held in Treasury, at Cost
- Treasury shares showed a growing negative proportion from -14.84% in March 2020 to around -22.16% by late 2024, with a slight recovery near -20.40% by early 2025, indicating increasing buybacks or retained shares over time.
- Earnings Employed in the Business
- This component steadily increased from 38.62% in early 2020 to 58.58% by March 2025, suggesting accumulation of retained earnings and stronger reinvestment or profitability contributing to equity growth.
- Accumulated Other Comprehensive Loss
- There was a steady reduction in the comprehensive loss from -14.06% in early 2020 to -9.11% by early 2025, indicating an improvement in components such as foreign currency translation or other comprehensive income items.
- Total Abbott Shareholders’ Investment
- Shareholders’ equity generally increased over the observed period, rising from 45.25% to nearly 59.93% by early 2025, reflecting stronger equity base in the capital structure overall.
- Noncontrolling Interests in Subsidiaries
- Noncontrolling interests remained relatively stable around 0.29% to 0.33%, showing no significant change in minority interests.
- Total Shareholders’ Investment
- The total shareholders’ investment increased steadily from 45.57% in March 2020 to 60.24% by March 2025, indicating a shift toward greater equity financing and a reduction in leverage.
- Total Liabilities and Shareholders’ Investment
- Remained constant at 100%, serving as the base for all ratios reported.